Abstract
Background: Defective folding and trafficking of β-cell ATP-sensitive potassium (KATP) channels causes congenital hyperinsulinism. Results: Carbamazepine improves the processing and surface expression of trafficking-impaired KATP channels harboring a subset of sulfonylurea receptor 1 mutations. Conclusion: Carbamazepine is a novel corrector of KATP channels. Significance: Carbamazepine may be used to treat congenital hyperinsulinism caused by defective KATPchannel trafficking.
Original language | English (US) |
---|---|
Pages (from-to) | 20942-20954 |
Number of pages | 13 |
Journal | Journal of Biological Chemistry |
Volume | 288 |
Issue number | 29 |
DOIs | |
State | Published - Jul 19 2013 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Cell Biology